| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.26 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |